
Xgeva (denosumab) is a RANK ligand inhibitor indicated for the prevention of skeletal-related events in patients with bone metastases from solid tumors. Each single-dose vial contains 120 mg of denosumab in 1.7 mL solution for subcutaneous administration. Supplied as a sterile, preservative-free injection.
Sorted by lowest price · Add now, sign in at checkout


Sorted by lowest price · Add now, sign in at checkout

Xgeva (denosumab) is a RANK ligand inhibitor indicated for the prevention of skeletal-related events in patients with bone metastases from solid tumors. Each single-dose vial contains 120 mg of denosumab in 1.7 mL solution for subcutaneous administration. Supplied as a sterile, preservative-free injection.
1 vendor
Products you might be interested in